Ares Management (ARES) Prices 2.65M Share Offering at $134.75/sh

Ares Management Corporation (NYSE: ARES) today announced the pricing of its previously announced underwritten public offering (the “Offering”) of 2,650,000 shares of Class A common stock, par value $0.01 per share (“Class A common stock”), of the Company at a public offering price of $134.75 per share of Class A common stock. In addition, Ares has granted to the underwriters of the Offering an option to purchase up to an additional 397,500 shares of Class A common stock at the public offering price, less underwriting discounts and commissions. The Offering is expected to close on or about June 14, 2024, subject to customary closing conditions.

Ares intends to use the net proceeds from the Offering for general corporate purposes, including repayment of debt, strategic acquisitions and to fund growth initiatives.

A registration statement on Form S-3 relating to these securities has been filed with the Securities and Exchange Commission (the “SEC”) and has become effective. The Offering may be made only by means of a prospectus supplement and accompanying prospectus. A copy of the final prospectus supplement and accompanying prospectus related to the Offering can be obtained, when available, for free by visiting the SEC’s website at http://www.sec.gov or by contacting Morgan Stanley, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014.

This press release does not constitute an offer to sell or a solicitation of an offer to buy these securities, nor does it constitute an offer, solicitation or sale of these securities in any jurisdiction in which such offer, solicitation or sale is unlawful. Nothing in this press release constitutes an offer to sell or solicitation of an offer to buy any securities of Ares or an investment fund managed by Ares or its affiliates.

You May Also Be Interested In

• Rapid Line sees stock surge with no known corporate cause
• Cosmos Health posts 29% revenue rise but widens net loss in Q2 2026
• Aurora Cannabis acquires two UK pharma firms for £2.1 million